Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Engineers identify usability barriers in workplace exoskeleton systems

17

Jun 2026

Engineers identify usability barriers in workplace exoskeleton systems

Wearable exoskeletons can help reduce physical strain in the workplace and protect employees from injury, but the technology has yet to achieve widespread adoption. A new study published in PLOS One by engineers at The University of Texas at El Paso may explain why: The technology is still too complex and cumbersome for everyday use.

Media pressure makes high-calorie food cues feel longer to teen girls

17

Jun 2026

Media pressure makes high-calorie food cues feel longer to teen girls

In 55 French female adolescents, high-calorie food images were perceived as lasting longer than low-calorie images during a temporal bisection task. Perceived media pressure strengthened this time-distortion effect, while body appreciation showed tentative evidence of reducing it after accounting for eating-disorder risk.

Researchers eliminate embryonic senescent cells, triggering severe neurovascular flaws

17

Jun 2026

Researchers eliminate embryonic senescent cells, triggering severe neurovascular flaws

Among the body's most crucial protective features are the brain barrier systems, including the blood-brain and blood-cerebrospinal fluid (CSF) barriers. These barriers are made of highly specialized cells that allow essential nutrients to enter, yet repel dangerous toxins and pathogens that may be circulating in the bloodstream. Scientists have long known what these barriers do, but less about how they are built during development.

Higher BMI raises risk for 19 cancers as global review expands the obesity-cancer link

17

Jun 2026

Higher BMI raises risk for 19 cancers as global review expands the obesity-cancer link

A major systematic review and meta-analysis links higher BMI to increased risk of 19 cancer types, including leukemia, non-Hodgkin lymphoma, bladder cancer, and glioma, which were not previously recognized in major consensus reports. The study also reveals regional and sex-based variation in cancer risk, with genetic evidence generally supporting many observational links while highlighting the need for more diverse global cohorts.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.